The legacy of Viagra and the medicinal industry presents a complex picture for potential investors. Initially, copyright's hugely successful drug transformed the treatment of erectile dysfunction, generating substantial profits and defining the contemporary pharmaceutical landscape. However, exclusive rights expiration and the rise of alternative v